Is there any risk of rebound or worsening of vitiligo symptoms after discontinuing ruxolitinib?

Featuring Cheri Frey, MD | Assistant Professor, Dermatology & Residency Program Director Director of Cosmetic DermatologyHoward UniversityWashington, DC | Published June 01, 2024